Nova Patents
AT359796T

Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement

Abstract

This record has no abstract on file.

Term

Term ended

Expired 10 July 2021, 5.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

84 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
61677800United States of AmericaA

Members84

Family members, oldest first
DocumentOfficeKind
CA2272745A1CanadaA1
WO9841500A1World Intellectual Property Organization (WIPO)A1
AU6280098AAustraliaA
US5945410AUnited States of AmericaA
NO994489D0NorwayD0
NO994489LNorwayL
AU714390B2AustraliaB2
EP0971888A1European Patent Office (EPO)A1
BR9808010ABrazilA
NZ337262ANew ZealandA
JP2000513010AJapanA
US6127559AUnited States of AmericaA
KR20000076303ARepublic of KoreaA
US6277837B1United States of AmericaB1
CA2403232A1CanadaA1
WO0174765A1World Intellectual Property Organization (WIPO)A1
AU4787301AAustraliaA
US6306844B1United States of AmericaB1
US6316642B1United States of AmericaB1
CA2416187A1CanadaA1
WO0205824A1World Intellectual Property Organization (WIPO)A1
AU7330301AAustraliaA
KR100345820B1Republic of KoreaB1
US2002123638A1United States of AmericaA1
EP1243363A2European Patent Office (EPO)A2
JP2002283003AJapanA
KR20020075200ARepublic of KoreaA
US2002151528A1United States of AmericaA1
US2002153120A1United States of AmericaA1
BR0200894ABrazilA
CN1387967AChinaA
EP1268415A1European Patent Office (EPO)A1
MXPA02009325AMexicoA
KR20030016402ARepublic of KoreaA
EP1243363A3European Patent Office (EPO)A3
US6544969B2United States of AmericaB2
US2003073857A1United States of AmericaA1
EP1305030A1European Patent Office (EPO)A1
MXPA03000405AMexicoA
IL153908D0IsraelD0
BR0112453ABrazilA
EP0971888B1European Patent Office (EPO)B1
AT253046TAustriaT
ATE253046T1AustriaT1
DE69819312D1GermanyD1
US6667298B2United States of AmericaB2
JP2004500414AJapanA
DK0971888T3DenmarkT3
PT971888EPortugalE
JP2004509853AJapanA
US2004072804A1United States of AmericaA1
US2004082802A1United States of AmericaA1
ES2206893T3SpainT3
CN1501803AChinaA
DE69819312T2GermanyT2
HK1066487A1Hong Kong, ChinaA1
AU2001247873B2AustraliaB2
US6939868B2United States of AmericaB2
NZ521236ANew ZealandA
CA2272745CCanadaC
US2006003973A1United States of AmericaA1
AU2001273303B2AustraliaB2
AU2001273303B8AustraliaB8
CN1250225CChinaC
JP2006096759AJapanA
KR100572958B1Republic of KoreaB1
JP3786712B2JapanB2
NZ524018ANew ZealandA
NO321925B1NorwayB1
US7112579B2United States of AmericaB2
EP1305030B1European Patent Office (EPO)B1
AT359796TThis recordAustriaT
ATE359796T1AustriaT1
DE60127964D1GermanyD1
DK1305030T3DenmarkT3
ES2286129T3SpainT3
JP4035143B2JapanB2
DE60127964T2GermanyT2
IL153908AIsraelA
CA2403232CCanadaC
JP4955895B2JapanB2
EP1268415B1European Patent Office (EPO)B1
ES2420682T3SpainT3
BR9808010B1BrazilB1